FA
ABBV icon

FCG Advisors’s AbbVie ABBV Stock Holding History

FCG Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$291K Sell
3,318
-16
-0.5% -$1.51K 0.07% 143
2020
Q2 		$327K Sell
3,334
-12
-0.4% -$1.06K 0.09% 106
2020
Q1 		$255K Buy
3,346
+6
+0.2% +$511 0.07% 121
2019
Q4 		$296K Buy
3,340
+204
+7% +$16.9K 0.08% 126
2019
Q3 		$237K Buy
3,136
+201
+7% +$13.8K 0.07% 138
2019
Q2 		$213K Buy
2,935
+85
+3% +$6.68K 0.07% 145
2019
Q1 		$230K Sell
2,850
-282
-9% -$23.1K 0.08% 131
2018
Q4 		$289K Buy
3,132
+3
+0.1% +$264 0.11% 102
2018
Q3 		$296K Buy
3,129
+3
+0.1% +$284 0.1% 107
2018
Q2 		$290K Buy
3,126
+2
+0.1% +$195 0.11% 101
2018
Q1 		$296K Sell
3,124
-15
-0.5% -$1.65K 0.1% 100
2017
Q4 		$302K Buy
3,139
+19
+0.6% +$1.79K 0.11% 92
2017
Q3 		$277K Buy
3,120
+2
+0.1% +$152 0.1% 96
2017
Q2 		$226K Buy
3,118
+3
+0.1% +$202 0.08% 128
2017
Q1 		$203K Buy
+3,115
New +$196K 0.08% 117
2015
Q1 		– Sell
-3,665
Closed -$245K – 100
2014
Q4 		$245K Buy
+3,665
New +$231K 0.12% 96

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

FCG Advisors's ABBV Position: Q3 2020 in Review

FCG Advisors reduced its AbbVie (ABBV) stake by 0.48% in Q3 2020, selling an estimated $1.51K and leaving 3,318 shares worth $291K. The position accounts for 0.07% of the portfolio, ranked #143.

FCG Advisors first reported a position in ABBV in Q4 2014 and has held it in 16 quarters since. The position peaked at $327K in Q2 2020. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • FCG Advisors held 3,318 shares of AbbVie worth $291K as of Q3 2020.
  • FCG Advisors sold 16 AbbVie shares in Q3 2020, an estimated $1.51K.
  • AbbVie made up 0.07% of FCG Advisors's portfolio in Q3 2020, its #143 holding.
  • FCG Advisors first reported a position in AbbVie in Q4 2014 and has held it in 16 quarters since.
  • FCG Advisors's AbbVie position peaked at $327K in Q2 2020.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on FCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.